The four drugs, WHO says have been picked based on their performance against Covid-19 in animal, laboratory and clinical studies. The four will undergo rapid clinical trials within a study called SOLIDARITY (in which some 45 countries have already registered) with results expected next year. The US, France and India have already approved emergency use of Chloroquine or Hydroxychloroquine in treating Covid-19 patients. On Thursday, the US began its own clinical trials to treat 500 adult Covid-19 patients with Hydroxychloroquine. The WHO says while it has not approved any anti Covid-19 treatment, using unproven drugs on patients without their consent was unethical.

Source: Standard Digital April 12, 2020 21:00 UTC